Global burden of influenza as a cause of cardiopulmonary morbidity and mortality

William A. Fischer, Michelle Ng Gong, Satish Bhagwanjee, Jonathan Sevransky

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Severe acute respiratory infections, including influenza, are a leading cause of cardiopulmonary morbidity and mortality worldwide. Until recently, the epidemiology of influenza was limited to resource-rich countries. Emerging epidemiological reports characterizing the 2009 H1N1 pandemic, however, suggest that influenza exerts an even greater toll in low-income, resource-constrained environments where it is the cause of 5% to 27% of all severe acute respiratory infections. The increased burden of disease in this setting is multifactorial and likely is the result of higher rates of comorbidities such as human immunodeficiency virus, decreased access to health care, including vaccinations and antiviral medications, and limited healthcare infrastructure, including oxygen therapy or critical care support. Improved global epidemiology of influenza is desperately needed to guide allocation of life-saving resources, including vaccines, antiviral medications, and direct the improvement of basic health care tomitigate the impact of influenza infection on the most vulnerable populations.

Original languageEnglish (US)
Pages (from-to)325-336
Number of pages12
JournalGlobal Heart
Volume9
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Human Influenza
Morbidity
Mortality
Respiratory Tract Infections
Antiviral Agents
Epidemiology
Delivery of Health Care
Health Services Accessibility
Pandemics
Vulnerable Populations
Critical Care
Comorbidity
Vaccination
Vaccines
HIV
Oxygen
Infection
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Epidemiology
  • Community and Home Care

Cite this

Global burden of influenza as a cause of cardiopulmonary morbidity and mortality. / Fischer, William A.; Gong, Michelle Ng; Bhagwanjee, Satish; Sevransky, Jonathan.

In: Global Heart, Vol. 9, No. 3, 2014, p. 325-336.

Research output: Contribution to journalArticle

Fischer, William A. ; Gong, Michelle Ng ; Bhagwanjee, Satish ; Sevransky, Jonathan. / Global burden of influenza as a cause of cardiopulmonary morbidity and mortality. In: Global Heart. 2014 ; Vol. 9, No. 3. pp. 325-336.
@article{48a192be8cc24fe2a91f80b7edd1c55e,
title = "Global burden of influenza as a cause of cardiopulmonary morbidity and mortality",
abstract = "Severe acute respiratory infections, including influenza, are a leading cause of cardiopulmonary morbidity and mortality worldwide. Until recently, the epidemiology of influenza was limited to resource-rich countries. Emerging epidemiological reports characterizing the 2009 H1N1 pandemic, however, suggest that influenza exerts an even greater toll in low-income, resource-constrained environments where it is the cause of 5{\%} to 27{\%} of all severe acute respiratory infections. The increased burden of disease in this setting is multifactorial and likely is the result of higher rates of comorbidities such as human immunodeficiency virus, decreased access to health care, including vaccinations and antiviral medications, and limited healthcare infrastructure, including oxygen therapy or critical care support. Improved global epidemiology of influenza is desperately needed to guide allocation of life-saving resources, including vaccines, antiviral medications, and direct the improvement of basic health care tomitigate the impact of influenza infection on the most vulnerable populations.",
author = "Fischer, {William A.} and Gong, {Michelle Ng} and Satish Bhagwanjee and Jonathan Sevransky",
year = "2014",
doi = "10.1016/j.gheart.2014.08.004",
language = "English (US)",
volume = "9",
pages = "325--336",
journal = "Global Heart",
issn = "2211-8160",
publisher = "Elsevier Science & Technology",
number = "3",

}

TY - JOUR

T1 - Global burden of influenza as a cause of cardiopulmonary morbidity and mortality

AU - Fischer, William A.

AU - Gong, Michelle Ng

AU - Bhagwanjee, Satish

AU - Sevransky, Jonathan

PY - 2014

Y1 - 2014

N2 - Severe acute respiratory infections, including influenza, are a leading cause of cardiopulmonary morbidity and mortality worldwide. Until recently, the epidemiology of influenza was limited to resource-rich countries. Emerging epidemiological reports characterizing the 2009 H1N1 pandemic, however, suggest that influenza exerts an even greater toll in low-income, resource-constrained environments where it is the cause of 5% to 27% of all severe acute respiratory infections. The increased burden of disease in this setting is multifactorial and likely is the result of higher rates of comorbidities such as human immunodeficiency virus, decreased access to health care, including vaccinations and antiviral medications, and limited healthcare infrastructure, including oxygen therapy or critical care support. Improved global epidemiology of influenza is desperately needed to guide allocation of life-saving resources, including vaccines, antiviral medications, and direct the improvement of basic health care tomitigate the impact of influenza infection on the most vulnerable populations.

AB - Severe acute respiratory infections, including influenza, are a leading cause of cardiopulmonary morbidity and mortality worldwide. Until recently, the epidemiology of influenza was limited to resource-rich countries. Emerging epidemiological reports characterizing the 2009 H1N1 pandemic, however, suggest that influenza exerts an even greater toll in low-income, resource-constrained environments where it is the cause of 5% to 27% of all severe acute respiratory infections. The increased burden of disease in this setting is multifactorial and likely is the result of higher rates of comorbidities such as human immunodeficiency virus, decreased access to health care, including vaccinations and antiviral medications, and limited healthcare infrastructure, including oxygen therapy or critical care support. Improved global epidemiology of influenza is desperately needed to guide allocation of life-saving resources, including vaccines, antiviral medications, and direct the improvement of basic health care tomitigate the impact of influenza infection on the most vulnerable populations.

UR - http://www.scopus.com/inward/record.url?scp=84927608783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927608783&partnerID=8YFLogxK

U2 - 10.1016/j.gheart.2014.08.004

DO - 10.1016/j.gheart.2014.08.004

M3 - Article

C2 - 25667184

AN - SCOPUS:84927608783

VL - 9

SP - 325

EP - 336

JO - Global Heart

JF - Global Heart

SN - 2211-8160

IS - 3

ER -